Fri, February 17, 2023

Douglas Tsao Reiterated (CABA) at Strong Buy and Held Target at $11 on, Feb 17th, 2023

Douglas Tsao of HC Wainwright & Co., Reiterated "Cabaletta Bio, Inc." (CABA) at Strong Buy and Held Target at $11 on, Feb 17th, 2023.

Douglas has made no other calls on CABA in the last 4 months.



There are 3 other peers that have a rating on CABA. Out of the 3 peers that are also analyzing CABA, 0 agree with Douglas's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Douglas


  • Michael Ulz of "Morgan Stanley" Upgraded from Hold to Buy and Held Target at $16 on, Friday, January 27th, 2023
  • Derek Archila of "Wells Fargo" Maintained at Buy with Increased Target to $14 on, Tuesday, January 3rd, 2023
  • Geulah Livshits of "Chardan Capital" Maintained at Strong Buy with Decreased Target to $12 on, Friday, November 11th, 2022